Off-Label Donepezil Rx for MCI Could Be Risky for Some Patients

Share this content:
Off-Label Donepezil Rx for MCI Could Be Risky for Some Patients
Off-Label Donepezil Rx for MCI Could Be Risky for Some Patients

WEDNESDAY, March 8, 2017 (HealthDay News) -- Donepezil should not be prescribed to patients with mild cognitive impairment without first giving them a genetic test, according to research published recently in the Journal of Alzheimer's Disease.

Sophie Sokolow, Ph.D., an associate professor at the University of California, Los Angeles, School of Nursing, and colleagues examined data from a U.S. government-funded study published in 2005 that assessed donepezil as a possible treatment for mild cognitive impairment.

The researchers found that patients with the K-variant of the butyrylcholinesterase gene (BChE-K) who took donepezil deteriorated faster than those who took a placebo.

"BChE-K polymorphisms are associated with deleterious changes in cognitive decline in mild cognitive impairment patients treated with donepezil for three years," the authors write. "This indicates that BChE-K genotyping should be performed to help identify subsets of subjects at risk for donepezil therapy."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

Medicaid Expansion Ups Preemptive Listing for Kidney Transplant

Medicaid Expansion Ups Preemptive Listing for Kidney Transplant

From pre- to post-expansion period, 59 percent relative increase in Medicaid-covered preemptive listings

BCG Vaccine Tied to Reduced Hyperglycemia in Type 1 Diabetes

BCG Vaccine Tied to Reduced Hyperglycemia in Type ...

Systemic shift in glucose metabolism from oxidative phosphorylation to aerobic glycolysis

Many Physicians Not Prepared for End-of-Life Talks With Patients

Many Physicians Not Prepared for End-of-Life Talks With ...

Additional training, reimbursement may foster these critical conversations, authors say

is free, fast, and customized just for you!




Already a member?

Sign In Now »